Mettrum Health Corp.

Mettrum Health Corp.

November 04, 2015 16:00 ET

Mettrum Announces Stock Option Grant

TORONTO, ONTARIO--(Marketwired - Nov. 4, 2015) - Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT), a vertically integrated health and wellness company focused on research, development, production and distribution of cannabis products, today announced that in connection with the previously announced appointment of Mr. George Scorsis as President of Mettrum, effective October 2, 2015, and following approval by the Board of Directors of the Company, 150,000 stock options to purchase common shares of the Company were granted to Mr. Scorsis. The stock options have an exercise price of $1.52 per share, equal to the closing price of Mettrum's common shares on October 2, 2015. The stock options vest equally over three years, and have a five-year term and were granted and shall be governed in accordance with the terms of the Company's stock option plan.

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., the wholly owned subsidiary of the Company, is a Toronto-based company incorporated under the laws of the Province of Ontario and a licensed producer under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license to produce medical cannabis from Health Canada on November 1, 2013 and began production of medical cannabis on the same date at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada on December 11, 2014 for its acquired Agripharm facility in Clearview, Ontario. With the Company's two licenses, Mettrum is a leading producer and vendor of medical marijuana under the MMPR system.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

Contact Information